Pontus Strålin1, Maria Skott2, Johan Cullberg3. 1. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. 2. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. maria.skott@sll.se. 3. Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Abstract
PURPOSE: New hospitalizations after first episode psychosis (FEP) may be viewed as an indicator of instability in a psychotic disorder. In the current study we wanted to analyse long term risk for psychosis hospitalizations after FEP. We also wanted to analyse predictors for late hospitalizations, with focus on early antipsychotic medication. METHODS: First episode psychosis cases were recruited to the Swedish Parachute project in 1996-1997. The program offered highly available and continuous psychosocial support and a cautious use of antipsychotic medication for 5 years from inclusion. Longitudinal data from population registers on psychiatric hospitalizations up to 14 years after inclusion were analysed. One hundred and sixty-one cases were included of the original 175 in the project. Associations with possible early predictive factors from the original project data were analysed with COX regression. RESULTS: A majority of the cases (67%) had hospitalizations in the first year after inclusion in the study. The cohort then diverged into a group (46%) with new hospitalizations for psychosis after the first year, most of them multiple times, and another group (54%) without new hospitalizations for psychosis, many without any late antipsychotic medication. Forty-two percentage of the cases had antipsychotic medication by month 12, and it was significantly associated with later psychosis hospitalizations (HR = 2.5, p value < 0.001). CONCLUSIONS: The study demonstrates that a large part of FEP cases have a good outcome as measured by absence of new hospitalizations for psychosis, and that many cases may terminate antipsychotic medication within a year of FEP onset without later relapses needing hospitalizations.
PURPOSE: New hospitalizations after first episode psychosis (FEP) may be viewed as an indicator of instability in a psychotic disorder. In the current study we wanted to analyse long term risk for psychosis hospitalizations after FEP. We also wanted to analyse predictors for late hospitalizations, with focus on early antipsychotic medication. METHODS: First episode psychosis cases were recruited to the Swedish Parachute project in 1996-1997. The program offered highly available and continuous psychosocial support and a cautious use of antipsychotic medication for 5 years from inclusion. Longitudinal data from population registers on psychiatric hospitalizations up to 14 years after inclusion were analysed. One hundred and sixty-one cases were included of the original 175 in the project. Associations with possible early predictive factors from the original project data were analysed with COX regression. RESULTS: A majority of the cases (67%) had hospitalizations in the first year after inclusion in the study. The cohort then diverged into a group (46%) with new hospitalizations for psychosis after the first year, most of them multiple times, and another group (54%) without new hospitalizations for psychosis, many without any late antipsychotic medication. Forty-two percentage of the cases had antipsychotic medication by month 12, and it was significantly associated with later psychosis hospitalizations (HR = 2.5, p value < 0.001). CONCLUSIONS: The study demonstrates that a large part of FEP cases have a good outcome as measured by absence of new hospitalizations for psychosis, and that many cases may terminate antipsychotic medication within a year of FEP onset without later relapses needing hospitalizations.
Authors: Wenche Ten Velden Hegelstad; Tor K Larsen; Bjørn Auestad; Julie Evensen; Ulrik Haahr; Inge Joa; Jan O Johannesen; Johannes Langeveld; Ingrid Melle; Stein Opjordsmoen; Jan Ivar Rossberg; Bjørn Rishovd Rund; Erik Simonsen; Kjetil Sundet; Per Vaglum; Svein Friis; Thomas McGlashan Journal: Am J Psychiatry Date: 2012-04 Impact factor: 18.112
Authors: Karin Landolt; Wulf Rössler; Vladeta Ajdacic-Gross; Eske M Derks; Jan Libiger; René S Kahn; W Wolfgang Fleischhacker Journal: Schizophr Res Date: 2016-02-26 Impact factor: 4.939
Authors: Toby T Winton-Brown; Thomas Elanjithara; Paddy Power; Ricardo Coentre; Pablo Blanco-Polaina; Philip McGuire Journal: Schizophr Res Date: 2016-10-10 Impact factor: 4.939
Authors: Lisa P Henry; G Paul Amminger; Meredith G Harris; Hok Pan Yuen; Susy M Harrigan; Amy L Prosser; Orli S Schwartz; Simone E Farrelly; Helen Herrman; Henry J Jackson; Patrick D McGorry Journal: J Clin Psychiatry Date: 2010-06 Impact factor: 4.384
Authors: D R Gotfredsen; R S Wils; C Hjorthøj; S F Austin; N Albert; R G Secher; A A E Thorup; O Mors; M Nordentoft Journal: Psychol Med Date: 2017-04-06 Impact factor: 7.723
Authors: Stephen F Austin; Ole Mors; Rikke Gry Secher; Carsten R Hjorthøj; Nikolai Albert; Mette Bertelsen; Heidi Jensen; Pia Jeppesen; Lone Petersen; Lasse Randers; Anne Thorup; Merete Nordentoft Journal: Schizophr Res Date: 2013-08-08 Impact factor: 4.939
Authors: Markus Jäger; Prisca Weiser; Thomas Becker; Karel Frasch; Gerhard Längle; Daniela Croissant; Tilman Steinert; Susanne Jaeger; Reinhold Kilian Journal: Psychiatry Res Date: 2013-12-07 Impact factor: 3.222